NCT04015687View on ClinicalTrials.gov

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Healthy Participants
Interventions
DRUG

AG-881

Supplied as uncoated tablets.

DRUG

Lamotrigine

Supplied as tablets of LAMICTAL® or generic equivalent.

Trial Locations (1)

85283

Celerion, Inc, Tempe

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY